QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text PDF Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perreault, S. Articles by Collin, J. Search for Related Content PubMed PubMed Citation Articles by Perreault, S. Articles by Collin, J.

HYPERTENSION

Persistence with Treatment in Newly Treated Middle-Aged Patients with Essential Hypertension

Assistant Professor, Faculty of Pharmacy, University of Montreal, Québec, Canada

Diane Lamarre, MSc

Clinical Teacher, Faculty of Pharmacy, University of Montreal

Lucie Blais, PhD

Assistant Professor, Faculty of Pharmacy, University of Montreal

Alice Dragomir, MSc

Research Assistant, Faculty of Pharmacy, University of Montreal

Djamal Berbiche, PhD

Research Assistant, Faculty of Pharmacy, University of Montreal

Lyne Lalonde, PhD

Assistant Professor, Faculty of Pharmacy, University of Montreal

Claudine Laurier, PhD

Full Professor, Faculty of Pharmacy, University of Montreal

François St-Maurice, MD

Assistant Professor, Faculty of Medicine, University of Montreal

Johanne Collin, PhD

Associate Professor, Faculty of Pharmacy, University of Montreal

Reprints: Dr. Perreault, Faculty of Pharmacy, PO Box 6128, Centre-Ville Station, Montreal, Québec H3C 3J7, Canada, fax 514/343-5691, sylvie.perreault{at}umontreal.ca

BACKGROUND: Antihypertensive agents have been found to decrease morbidity and/or mortality associated with cardiovascular disease (CVD). Surveys have shown that hypertension has been diagnosed in many patients but remains uncontrolled. One factor may be the lack of persistence to treatment.

OBJECTIVE: To evaluate persistence with antihypertensives and its determinants among newly treated patients.

METHODS: A cohort of 21 011 patients with essential hypertension was reconstructed from prescription records in the Régie de l'assurance maladie du Québec administrative database. We included subjects between 50 and 64 years of age newly treated for hypertension with diuretics, ß-blockers, angiotensin-converting enzyme inhibitors, calcium-channel blockers, or angiotensin II receptor blockers prescribed individually or in combination. Cohort entry was from January 1, 1998, to December 31, 2000. Subjects were considered newly treated if they had not taken any antihypertensive agents in the year prior to the index date, which was defined as the date of the first prescription. Patients were followed until June 30, 2001; death; end of coverage; or occurrence of CVD. Main outcome measure was the persistence rate. The cumulative persistence rate was determined by Kaplan–Meier analysis. The rate ratio of discontinuing antihypertensive therapy was estimated using the Cox regression model.

RESULTS: The mean age of patients was 58 years. Persistence with antihypertensive therapy fell to 75% in the first 6 months after treatment and continued to decline over the next 3 years to 55%. During a one-year period of follow-up, with diuretics used as the reference class and controlling for several variables, patients prescribed other antihypertensive classes or combined therapy (HR 0.71; 95% CI 0.67 to 0.75) were found to have a better rate of persistence. Having diabetes (HR 0.86; 95% CI 0.79 to 0.94) and dyslipidemia (HR 0.71; 95% CI 0.66 to 0.76) increased the rate of persistence. Similar values were observed during the 3-year period of follow-up.

CONCLUSIONS: Barriers to persistence occur early in the course of therapy, and adherence continues to decline over a period of 3 years. Patients were least persistent to diuretic therapy.

Key Words: hypertension, antihypertensive agents: determinants, persistence

Published Online, August 2, 2005. www.theannals.com, DOI 10.1345/aph.1E548

This article has been cited by other articles:

				R. D. Feldman, G. Y. Zou, M. K. Vandervoort, C. J. Wong, S. A.E. Nelson, and B. G. Feagan A Simplified Approach to the Treatment of Uncomplicated Hypertension: A Cluster Randomized, Controlled Trial Hypertension, April 1, 2009; 53(4): 646 - 653. [Abstract] [Full Text] [PDF]

				C. Naughton, J. Feely, and K. Bennett A clustered randomized trial of the effects of feedback using academic detailing compared to postal bulletin on prescribing of preventative cardiovascular therapy Fam. Pract., October 1, 2007; 24(5): 475 - 480. [Abstract] [Full Text] [PDF]

				J. George, K. Munro, D. J McCaig, and D. C Stewart Prescription Medications: Beliefs, Experiences, Behavior, and Adherence of Sheltered Housing Residents Ann. Pharmacother., December 1, 2006; 40(12): 2123 - 2129. [Abstract] [Full Text] [PDF]